Table 2.
Descriptive Characteristics of Included Participants.
| Characteristic, mean (SD) unless otherwise stated | N = 93 |
|---|---|
| Sex, female, n (%) | 34 (36.6) |
| Age (years) | 71.0 (6.1) |
| Body mass index (kg/m2) | 25.3 (3.5) |
| Education (years) | 14.8 (3.0) |
| Years with diagnosis | 5.2 (4.5) |
| Levodopa equivalent dose (mg/day) | 554.1 (331.3) |
| Hoehn & Yahr | |
| 2, n (%) | 71 (76.3) |
| 3, n (%) | 22 (23.7) |
| People who fell in previous 6 months, n (%) | 29 (31.2) |
| Montreal Cognitive Assessment (0-30) | 25.8 (2.4) |
| Cognitive status (4 missing) | |
| PD non-MCI, n (%) | 39 (41.9) |
| PD MCI, n (%) | 26 (28.0) |
| Intermediatea, n (%) | 24 (25.8) |
| Activities-specific Balance Confidence scale (0-100) | 79.4 (16.2) |
| Walk-12 scale (0-46) | 11.9 (8.4) |
| Mini Balance Evaluation Systems Test (0-28) | 20.9 (3.5) |
| Timed Up and Go (seconds) | 10.8 (2.7) |
| MDS-UPDRS, Part III, motor examination (0-132) | 31.1 (11.2) |
| EuroQol Visual Analogue Scale (%) | 72.7 (15.3) |
| PDQ-39, Summary Index (0-100) | 20.7 (12.4) |
| HADS anxiety subscale (0-21) | 4.2 (3.3) |
| HADS depression subscale (0-21) | 3.2 (2.8) |
Abbreviations: MDS-UPDRS, Movement Disorder Society–Unified Parkinson’s Disease Rating Scale; PDQ-39, Parkinson’s Disease Questionnaire–39; HADS, Hospital Anxiety and Depression Scale.
a
Participants who could not with certainty be classified as either PD MCI or PD non-MCI.